Skip to content

Tectonic Therapeutics TECX Other Income (Expense)

Other Income (Expense) at other companies

ALN
Alnylam PharmaceuticalsALNY
-$46.98M-130%
Septerna, Inc. logo
Septerna, Inc.SEPN
$5M+12.8%
Regenxbio logo
RegenxbioRGNX
-$6.69M-10.7%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$29K-72.9%
Opko Health logo
Opko HealthOPK
-$9.94M-60.2%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$4.77M-112%

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$585.51M+58.3%
Enterprise value$353.51M+438%

Returns & leverage

See full
Return on equity-31.4%
Debt / equity0.0×
Current ratio18.5×-4.4×

Where this comes from

Reported directly by Tectonic Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tectonic Therapeutics's other income (expense)?
Tectonic Therapeutics (TECX) reported other income (expense) of $2.06M in Q1 2026.
How has Tectonic Therapeutics's other income (expense) changed year-over-year?
Tectonic Therapeutics's other income (expense) decreased by 13.9% year-over-year, from $2.39M to $2.06M.
What is the long-term trend for Tectonic Therapeutics's other income (expense)?
Over 3 years (2021 to 2025), Tectonic Therapeutics's other income (expense) has grown at a 239.1% compound annual growth rate (CAGR), from -$285K to $11.12M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.